Immunization, HepB3 in IDA total
IDA total: Immunization, HepB3 was 76.6% in 2024. ◆ Volatile
Immunization, HepB3 in IDA total, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
IDA total recorded 76.6% for immunization, hepb3 in 2024.
That represents a change of up 0.2% on the previous year and up 4.9% over ten years.
Over the whole period, immunization, hepb3 in IDA total peaked at 78.9% in 2019 and was at its lowest, 0.0%, in 1985.
That places IDA total 37th out of 47 groups with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in IDA total, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.1% | +1836.6% |
| 1991 | 0.2% | +104.2% |
| 1992 | 0.2% | -30.1% |
| 1993 | 0.5% | +254.1% |
| 1994 | 1.2% | +115.9% |
| 1995 | 1.4% | +18.9% |
| 1996 | 1.7% | +19.2% |
| 1997 | 1.8% | +5.7% |
| 1998 | 1.8% | +5.0% |
| 1999 | 2.5% | +33.7% |
| 2000 | 3.7% | +50.4% |
| 2001 | 4.5% | +21.8% |
| 2002 | 17.5% | +286.6% |
| 2003 | 30.0% | +71.2% |
| 2004 | 34.9% | +16.5% |
| 2005 | 45.2% | +29.4% |
| 2006 | 53.1% | +17.6% |
| 2007 | 65.5% | +23.4% |
| 2008 | 68.3% | +4.2% |
| 2009 | 72.2% | +5.7% |
| 2010 | 70.2% | -2.7% |
| 2011 | 70.8% | +0.8% |
| 2012 | 70.7% | -0.2% |
| 2013 | 71.6% | +1.4% |
| 2014 | 73.0% | +1.9% |
| 2015 | 73.3% | +0.4% |
| 2016 | 75.8% | +3.4% |
| 2017 | 76.0% | +0.2% |
| 2018 | 77.4% | +1.9% |
| 2019 | 78.9% | +1.9% |
| 2020 | 76.1% | -3.5% |
| 2021 | 74.7% | -1.8% |
| 2022 | 75.8% | +1.4% |
| 2023 | 76.5% | +0.9% |
| 2024 | 76.6% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 1.1% | 0.1% | 2.5% | 10 |
| 2000s | 39.5% | 3.7% | 72.2% | 10 |
| 2010s | 73.8% | 70.2% | 78.9% | 10 |
| 2020s | 75.9% | 74.7% | 76.6% | 5 |
More health data for IDA total
- Population ages 65 and above, male, per capita 0.0179 units per person (2025)
- Population, male, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population, male, annual growth rate 2.11 % change on previous year (2025)
- Population, female, per capita 0.5007 units per person (2025)
- Population, female, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population, female, annual growth rate 2.12 % change on previous year (2025)
- Population ages 65 and above, total, per capita 0.0396 units per person (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, annual growth rate 3.7 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0004 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hepb3 in IDA total?
- Immunization, hepb3 in IDA total was 76.6% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in IDA total?
- The highest recorded value was 78.9% in 2019.
- What is the lowest immunization, hepb3 recorded in IDA total?
- The lowest recorded value was 0.0% in 1985.
- How does IDA total rank for immunization, hepb3?
- IDA total ranks 37th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in IDA total?
- Over the last ten years it is up 4.9%. The long-run trend across the full record is volatile.
- Where does this IDA total data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.